An observational study in Acute Low Back Pain and Chronic Low Back Pain (CLBP), sponsored by Bern University of Applied Sciences. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Bern University of Applied Sciences · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 46 studies in Low Back Pain with a site in Switzerland — 8 open to participants now, 8 under way, none of them phase 3. Low Back Pain · Switzerland.
Among the 46 studies in Low Back Pain with a site in Switzerland, this one has the largest planned enrollment of the 15 observational ones that give a count, is one of 2 that started in 2025, is one of 15 observational ones, and was the 45th registered.
2,923 studies on the registry are indexed under Low Back Pain; 579 are open to participants now.
Browse Low Back Pain studies →8 of the 46 studies in Low Back Pain with a site in Switzerland are open now. Recruiting first, the newest first:
Guillaume Christe · Sites in Switzerland
Ages 18+
Claudio Perret · Sites in Switzerland
Ages 18–65
Stephane ARMAND · Sites in Switzerland
Ages 18–65
University Hospital, Geneva · Sites in Switzerland
Ages 18+
Li Yiming · Sites in Switzerland
Ages 18–75
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 332 Low Back Pain studies recruiting now, 92 (28%) set no upper age limit and 210 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
46 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 100 across 482 observational studies indexed under Low Back Pain.
Median enrollment 102 across the 31 interventional studies, 105 across the 15 observational. Of the 35 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 46 have an industry lead sponsor. The 10 most frequent:
Bern University of Applied Sciences is the lead sponsor of 21 studies on the registry; 3 are open to participants now.
Bern University of Applied Sciences has 3 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 46 studies in Low Back Pain with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Low back pain (LBP) is a major health problem in Switzerland and worldwide. Globally, LBP remains the leading cause of years lived with disability and its incidence and associated socioeconomic consequences are predicted to increase in the coming decades. In Switzerland, the condition is one of the most commonly reported physical complaints and negatively affects quality of life, resulting in significant personal burden and personal financial burden. LBP also generates enormous socioeconomic costs, with both direct and indirect costs estimated to reach billions of Swiss francs in Switzerland annually. Therefore, it is essential that LBP prevention, diagnosis, and management are improved.
LBP is a multifactorial condition. Social, psychological and biophysical factors, along with comorbidities and genetic factors, influence LBP development and associated disability. In individuals with LBP, psychological factors, such as pain catastrophizing, are associated with higher pain intensity and developing chronic LBP and the associated disability. Among biophysical factors, altered spinal motor behaviour (e.g. smaller trunk movement amplitude) and reduced physical activity have been observed in LBP patients and suggested to influence LBP. However, exactly how all these factors influence LBP and how they are interrelated remains unclear. In particular, the effect of altered spinal motor behaviour on LBP is not understood. However, altered motor behaviour could play an important role in changing LBP and related disability. Therefore, improving our understanding of the patterns of spinal motor behaviour and the interrelationships with other factors in LBP would increase our understanding of LBP progression and could help improve LBP management.
This study consists of a 6-month prospective longitudinal cohort observation of spinal motor behavior, physical activity, psychological factors, pain intensity, and disability in LBP patients (300 acute, 300 chronic LBP). Data collection will occur remotely and the frequency of repeated measures will be daily or weekly, depending on the measure. A custom smart-phone application will be used by participants to collect data on spinal motor behavior, psychological factors, pain intensity, and disability. Physical activity will be monitored using a wearable physical activity tracker.
Established trajectories of motor behavior will be investigated for potential interrelations with trajectories of other parameters (e.g. pain, psychological factors, and disability), to explore potential causal effects. In addition, risk factors or predictive factors for certain trajectories of motor behavior and other parameters will be identified. As such, this study will allow us to investigate the temporality of these relationships and identify LBP, and in particular spinal motor behavior, phenotypes.
Patients will be recruited from ambulatory medical, physiotherapy and rehabilitation clinics in northern, central and western Switzerland (cantons: Bern, Zürich, Basel, Aargau, Luzern, Zug, Schwyz, Vaud, Fribourg, Wallis, and Neuchâtel).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with an acute low back pain episode (\<3 months of low back pain upon study enrollment)
Other: Observational
Patients with chronic low back pain (\>3 months of low back pain upon study enrollment)
Other: Observational
This study is observational of nature: multidimensional data is collected and no interventional is imposed
Spinal motion: maximum movement amplitude
Spine motion is recorded during multiple repetitions of several clinically relevant motions (trunk flexion, trunk extension, left/right trunk lateral flexion while standing), as well as a functional motion (picking up a lightweight object from the floor). The motion is measured using the internal inertial sensors of the patient's smartphone. The first main variable of interest is maximum movement amplitude (unit: degrees). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Spinal motion: maximum/average movement velocity
Spine motion is recorded during multiple repetitions of several clinically relevant motions (trunk flexion, trunk extension, left/right trunk lateral flexion while standing), as well as a functional motion (picking up a lightweight object from the floor). The motion is measured using the internal inertial sensors of the patient's smartphone. The second main variable of interest is maximum/average movement velocity (unit: degrees/second). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Movement-evoked low back pain
Movement-evoked low back pain (pain during movement) will be scored by patients on an 11-point numerical pain rating scale (0-10; whole-point, with 0 being 'no pain' and 10 'the worst pain you can imagine'), for each spinal motion separately, directly after performing each movement. Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: movement pain-related fear
Pain-related fear will be assessed for each movement being measured, using an 11-point numerical rating scale (0-10; whole-point), with 0 being 'not harmful at all' and 10 'extremely harmful' (adapted from Photograph Series of Daily Activities-Short Electronic Version; PHODA-SeV). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: task-specific pain-related fear
Item four from the Photograph Series of Daily Activities-Short Electronic Version (PHODA-SeV), which shows a person lifting a pot, will be used to assess task-specific pain-related fear. Participants rate their fear on an 11-point numerical rating scale (0-10; whole-point), with 0 being 'not harmful at all' and 10 'extremely harmful'. Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: fear avoidance beliefs related to physical activity
The physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ) will be used to assess fear avoidance beliefs related to physical activity. Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: pain catastrophizing
Pain catastrophizing will be assessed using the Daily Pain Catastrophizing Scale (Daily PCS). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: self-efficacy
Self-efficacy will be measured using the 2-item short form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Psychological factors: stress
Stress across the last 24 hours will be assessed using the 11-point stress numerical rating scale (0-10, whole-point, with 0 being 'no stress' and 10 being 'worst stress imaginable'). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Physical activity: heart rate
Physical activity is measured continuously using a well-established, wrist-worn activity tracker. The first main variable of interest is heart rate (unit: beats per minute). Frequency of measurement: continuously during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Physical acitivity: step count
Physical activity is measured continuously using a well-established, wrist-worn activity tracker. The second main variable of interest is step count (unit: number of steps). Frequency of measurement: continuously during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Low back pain intensity
Average low back pain intensity, in the last 24 hours, will be scored by patients on an 11-point numerical pain rating scale (0-10; whole-point), with 0 being 'no pain' and 10 'the worst pain you can imagine'. Frequency of measurement: daily during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Disability: general level of disability (1)
General level of disability will be rated by patients using an 11-point numerical rating scale (0-10; whole-point, with 0 'not at all', 5 'moderate limitation', 10 'totally limited'). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Disability: general level of disability (2)
General level of disability will also be rated by patients using the Roland-Morris Disability Questionnaire (RMDQ). Frequency of measurement: 6-weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Disability: lift-specific disability
The LBP impact on the patient's ability to lift over the past 24 hours will be assessed using one single-item question and rated using an 11-point numeric rating scale (0-10; whole-point, with 0 being 'not al all', 5 'moderate limitation', 10 'totally limited'). Frequency of measurement: weekly during the 25-week study period.
Time frame: Up to 25 weeks from enrollment.
Patient demographics: sex
Data on sex (female, male, intersex) will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: gender
Data on gender (woman, man, non-binary, a term not listed, I am questioning/not sure) will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: occupational status
Data on occupational status will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: occupation
Data on current or recent occupation will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: work satisfaction
Data on work satisfaction (very unsatisfied; unsatisfied; neutral; satisfied; very satisfied; this is not relevant to me) will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: work expectation
Data on work expectation ('I think I will be able to do my regular job, without any restrictions, 4 weeks from now' and 'I think I will be able to do my regular job, without any restrictions, 3 months from now'; on a 7-point scale, 0-6 with 0 being 'unlikely' and 6 'definitely') will be collected using a questionnaire.
Time frame: At enrollment
Patient demographics: highest education
Data on highest education will be collected using a questionnaire.
Time frame: At enrollment
Patient anthropometry: body mass
Patient body mass (unit: kg) will be collected using a questionnaire
Time frame: At enrollment
Patient anthropometry: height
Patient height (unit: m) data will be collected using a questionnaire
Time frame: At enrollment
Basic low back pain history: duration
Data on duration of low back pain symptoms will be collected using a questionnaire
Time frame: At enrollment
Basic low back pain history: other
Data on location and previous episodes of low back pain symptoms, and other diagnoses or previous surgeries will be collected using a questionnaire.
Time frame: At enrollment
Low back pain beliefs
Data on low back pain beliefs will be collected using the BackPAQ questionnaire.
Time frame: At enrollment
Basic medical status: smoking status
Data on smoking status (yes; no, not anymore; no, never) will be collected using a questionnaire
Time frame: At enrollment
Basic medical status: comorbidities
Data on comorbidities will be collected using a questionnaire
Time frame: At enrollment
Basic medical status: anxiety
Data on anxiety will be collected using a questionnaire on an 11-point scale (0-10, whole-point) numerical rating scale, with 0 being 'not at all' and 10 'quite anxious'.
Time frame: At enrollment
Basic medical status: depression
Data on depression will be collected using a questionnaire on an 11-scale (0-10, whole-point) numerical rating scale, with 0 being 'never' and 10 'all the time'.
Time frame: At enrollment
Basic medical status: stress
Data on stress will be collected using the perceived stress scale 4 questionnaire, with for each of the four questions a 5-point scale (0-4, whole-point, with 0 being 'never' and 4 'very often').
Time frame: At enrollment
Basic medical status: medication and treatment
Data on medication as well as previous and current treatment will be collected using a questionnaire
Time frame: At enrollment
Basic medical status: neuropathic pain
Data on neuropathic pain symptoms will be collected using the first two questions of neuropathic pain diagnosis questionnaire (DN4). For both questions, participants select symptoms from a list, with each selected symptom scored as +1, with a total score of larger than or equal to 3 indicating neuropathic pain.
Time frame: At enrollment
Plan to share: Yes — Data will be stored in a private repository during the project and, upon its completion, will be made publicly available on the Swiss-based data management portal OLOS under a CC0 license. OLOS was chosen because it supports the FAIR principles and offers robust long-term preservation features. Data not publicly released on OLOS will be accessible upon reasonable request.
Supporting information: Study protocol, Statistical analysis plan
Time frame: The study protocol, including the statistical analysis plan, will be published in a scientific journal before the end of the data collection. All other publicly made data will be available indefinitely upon completion of the project.
Access criteria: Everyone via OLOS or upon reasonable request.
Started Oct 2025 (actual). Primary completion is estimated for May 2028, 31 months after the start.
Of 176 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 31 months is above that.
Counting every sponsor, half of 186 studies reached it within 24 months; a quarter within 10 and three quarters within 48.
Start moved once since we started tracking on Sep 25, 2026: Sep 2025 → Oct 2025, on Oct 7, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bern University of Applied Sciences